About Adapsyn
Adapsyn is a company based in Hamilton (United States) founded in 2016 by Nathan Magarvey.. Adapsyn offers products and services including Genomics Platform, Metabolomics Platform, and Assay Biology Platform. Adapsyn operates in a competitive market with competitors including Evelo Biosciences, Kallyope, PathogenDX, Manus Bio and Newcells Biotech, among others.
- Headquarter Hamilton, United States
- Founders Nathan Magarvey
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Adapsyn Bioscience Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
Gates Foundation
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Adapsyn
Adapsyn offers a comprehensive portfolio of products and services, including Genomics Platform, Metabolomics Platform, and Assay Biology Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Identifies microbial strains for novel chemistry and drug prediction.
Detects compounds from microbes for evaluation and isolation.
Generates chemical libraries for screening and biochemical assays.
Unlock access to complete
Unlock access to complete
Board Team
4 people
Leadership Team
2 people
Software Development Team
2 people
Operations Team
1 people
Unlock access to complete
Funding Insights of Adapsyn
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2022 | Amount | Grant - Adapsyn | Valuation |
investors |
|
| Jan, 2018 | Amount | Seed - Adapsyn | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Adapsyn
Adapsyn has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Gates Foundation, Genesys Capital and Pfizer Venture Investments. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage life sciences companies are supported through venture capital investments.
|
Founded Year | Domain | Location | |
|
Venture capital is focused on healthcare by Pfizer's investment arm.
|
Founded Year | Domain | Location | |
|
Charitable foundation investments on poverty reduction and healthcare
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Adapsyn
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Adapsyn
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Adapsyn Comparisons
Competitors of Adapsyn
Adapsyn operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evelo Biosciences, Kallyope, PathogenDX, Manus Bio and Newcells Biotech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for inflammatory diseases, COVID-19, and cancer are developed.
|
|
| domain | founded_year | HQ Location |
The gut-brain axis is explored for therapeutic and nutritional innovations.
|
|
| domain | founded_year | HQ Location |
Provider of DNA-based pathogen testing kits
|
|
| domain | founded_year | HQ Location |
Phytochemicals are developed using microbial fermentation processes.
|
|
| domain | founded_year | HQ Location |
Induced pluripotent stem cell-derived organoid models are developed for research.
|
|
| domain | founded_year | HQ Location |
Cell-based assays and 3D microtissues for drug screening are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Adapsyn
Frequently Asked Questions about Adapsyn
When was Adapsyn founded?
Adapsyn was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Where is Adapsyn located?
Adapsyn is headquartered in Hamilton, United States.
What does Adapsyn do?
Adapsyn was founded in 2016 in Hamilton, United States. Computational tools are offered for bacterial metabolomic and genomic data analysis within the biotechnology sector. Proprietary machine learning is applied to microbial data to identify natural products encoded in genomes. Technology platforms such as PRISM, GARLIC, GRAPE, CLAMS, and ADAPSYN GRAPH are utilized for artificial intelligence in natural product drug discovery.
Who are the top competitors of Adapsyn?
Adapsyn's top competitors include PathogenDX, Manus Bio and Newcells Biotech.
What products or services does Adapsyn offer?
Adapsyn offers Genomics Platform, Metabolomics Platform, and Assay Biology Platform.
Who are Adapsyn's investors?
Adapsyn has 3 investors. Key investors include Gates Foundation, Genesys Capital, and Pfizer Venture Investments.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.